Analgesia in paediatric acute pancreatitis: A scoping systematic review.

Isabelle Scheers, Sanjay Pandanaboyana, Maisam Abu-El-Haija, Nejo Joseph, James Lucocq, Cecilie Sigaard Knoph, Asbjorn M Drewes

Journal: Journal of pediatric gastroenterology and nutrition 2025;80(1):203-208

PMID: 39563649

Abstract

OBJECTIVE

Acute pancreatitis (AP) is a common paediatric condition, yet there is little data to support optimal analgesic practice. The aim of this scoping review was to report analgesic practice, investigate trends in analgesic strategy and evaluate the impact of analgesic modality on outcomes.

METHODS

A systematic search of Medline, Embase, CENTRAL, Pubmed Central and Google Scholar was performed by two independent investigators. This review adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews checklist.

RESULTS

Three retrospective cohort studies, all conducted in North America, reported on analgesic practice in paediatric AP. The studies included 658 patients (median age, 12 years; female sex, 57%; non-biliary aetiology, 85.9%). Overall, analgesia was administered in 67% of patients, including opioids in 59.5% (43.8%-71.4%). Rates of acetaminophen (17.9% and 77.7%) and non-steroidal anti-inflammatory drugs (7.7% and 40.2%) were reported in two studies. Two studies reported reducing rates of opioid administration or reduced duration of opioid administration since 2017 and 2014, respectively. One study did not find any correlation between opioid administration and sociodemographic factors, length of stay or admission to intensive care units. No studies reported on complications or quality of life. No studies investigated non-medical modalities. There were no long-term data on analgesic use post-discharge.

CONCLUSIONS

Opioids are the mainstay of pain treatment in paediatric AP in North America. However, factors that influence the analgesic type, the impact of analgesic modality on the post-pancreatitis outcome and long-term analgesic use constitute a knowledge gap. Future studies are needed to inform analgesic use in paediatric AP.

© 2024 European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

Address: Department of General Surgery, NHS Lothian, Edinburgh, UK.; Palmerston North Hospital, Health New Zealand, Midcentral, Palmerston North, New Zealand.; Centre for Pancreatic Diseases, Department of Gastroenterology & Hepatology, Aalborg University, Aalborg, Denmark.; Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, College of Medicine, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, USA.; Paediatric Gastroenterology and Hepatology, Centre for Rare Pancreatic Diseases, Cliniques universitaires Saint-Luc, Woluwe-Saint-Lambert, Belgium.; HPB and Transplant Unit, Freeman Hospital, Newcastle Hospitals and NHS Foundation Trust, Newcastle Upon Tyne, UK.; Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.